A detailed history of Pro Share Advisors LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,205 shares of AXNX stock, worth $710,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,205
Previous 12,752 19.97%
Holding current value
$710,574
Previous $879,000 21.96%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$66.47 - $69.65 $169,299 - $177,398
-2,547 Reduced 19.97%
10,205 $686,000
Q1 2024

May 08, 2024

BUY
$56.67 - $69.36 $255,978 - $313,299
4,517 Added 54.85%
12,752 $879,000
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $91,846 - $118,575
1,860 Added 29.18%
8,235 $512,000
Q3 2023

Nov 13, 2023

SELL
$48.64 - $62.51 $340 - $437
-7 Reduced 0.11%
6,375 $357,000
Q2 2023

Aug 10, 2023

BUY
$47.99 - $60.21 $29,369 - $36,848
612 Added 10.61%
6,382 $322,000
Q1 2023

May 11, 2023

SELL
$52.6 - $67.34 $28,246 - $36,161
-537 Reduced 8.51%
5,770 $314,000
Q4 2022

Feb 02, 2023

BUY
$59.56 - $76.6 $53,782 - $69,169
903 Added 16.71%
6,307 $394,000
Q3 2022

Nov 04, 2022

BUY
$57.96 - $78.12 $7,418 - $9,999
128 Added 2.43%
5,404 $381,000
Q2 2022

Aug 01, 2022

SELL
$39.5 - $64.42 $131,061 - $213,745
-3,318 Reduced 38.61%
5,276 $299,000
Q1 2022

May 10, 2022

SELL
$43.74 - $62.76 $62,110 - $89,119
-1,420 Reduced 14.18%
8,594 $537,000
Q4 2021

Feb 08, 2022

BUY
$50.01 - $73.35 $207,041 - $303,669
4,140 Added 70.48%
10,014 $561,000
Q3 2021

Nov 12, 2021

SELL
$59.21 - $78.66 $291,786 - $387,636
-4,928 Reduced 45.62%
5,874 $382,000
Q2 2021

Aug 13, 2021

BUY
$51.39 - $66.9 $139,626 - $181,767
2,717 Added 33.61%
10,802 $685,000
Q1 2021

May 14, 2021

BUY
$49.14 - $59.89 $68,206 - $83,127
1,388 Added 20.73%
8,085 $484,000
Q4 2020

Feb 09, 2021

SELL
$42.19 - $51.5 $142,686 - $174,173
-3,382 Reduced 33.55%
6,697 $334,000
Q3 2020

Nov 13, 2020

SELL
$35.33 - $51.04 $11,022 - $15,924
-312 Reduced 3.0%
10,079 $514,000
Q2 2020

Aug 03, 2020

BUY
$22.91 - $39.83 $238,057 - $413,873
10,391 New
10,391 $365,000
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $155,505 - $356,888
-9,459 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$19.57 - $28.96 $185,112 - $273,932
9,459 New
9,459 $262,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.42B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.